Stay updated on Nivolumab in Salivary Gland Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Salivary Gland Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Salivary Gland Carcinoma Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 has been added and Revision: v3.4.2 has been removed, updating the page’s version label.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedA new system revision v3.4.2 was added, and the earlier revision v3.4.1 along with the notice about government funding status was removed. These updates do not affect the study details, eligibility criteria, or user-facing content.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center being open (with links to cc.nih.gov and opm.gov) was added, and the page revision was updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThe update adds a glossary toggle, updates the QC criteria label, adjusts the No FEAR Act data text, and changes the revision tag from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 has been added and v3.3.3 removed. No study content or results appear affected.SummaryDifference0.1%

- Check83 days agoChange DetectedFooter now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed; no substantive study information or data were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Salivary Gland Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Salivary Gland Carcinoma Clinical Trial page.